NCT03297177 - Autologous Stem/Stromal Cells in Neurological Disorders and Disease | Biotech Hunter

Enrollment

300

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

January 1, 2023

Study Completion Date

January 1, 2023

Conditions

DementiaParkinsonAltered Behavior in Alzheimer DiseaseDemyelinating Autoimmune Diseases, CNSDemyelinating Sensorimotor NeuropathyCorticobasal Degeneration

Interventions

PROCEDURE

Microcannula Harvest Adipose

Use Closed Syringe Microcannula Harvest Adipose, Autologous Subdermal Deposits

DEVICE

Centricyte 1000

Closed System, Digestive Isolation \& Concentration of AD-cSVF

PROCEDURE

Sterile Normal Saline Infusion

Sterile Normal Saline Re-Suspension of cSVF and Delivery of AD-cSVF via IV route

Trial Locations (2)

02760

Regeneris Medical Inc, North Attleboro

Regeneris Medical, North Attleboro